July 18, 2000Meperidine HCl Injection
Recalled by Wyeth Ayerst Laboratories
Chester, PA (SafetyAlerts) - The
Food and Drug Administration (FDA) today reported that Wyeth Ayerst Laboratories is
conducting a recall of Meperidine HCl Injection because of a lack of assurance of
Meperidine HCl Injection, USP, 75 mg/mL, 1 mL fill in 2 mL tubex(r), Rx.
Recall #D-431-0. Class II
Lot #2001276 EXP 1/02.
Wyeth Ayerst Laboratories, West Chester, Pennsylvania.
Manufacturer, by telephone on or about June 12, 2000. Firm-initiated recall ongoing.
This is the first public notice issued by the FDA.
343,124 units were distributed.
Questions concerning this recall may be directed
to the FDA at 1-888-INFO-FDA.
Notice of this product warning was sent via email
to SafeMail subscribers July 18,
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.